Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 166 | Sp2 | trade journal | 0.100 Q4 | 2 | 74 | 64 | 64 | 1 | 58 | 0.02 | 0.86 |  |
| 165 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 31 | 0 | 0 | 26 | 0.00 | 0.00 | |
| 164 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.101 Q4 | 40 | 0 | 17 | 0 | 0 | 17 | 0.00 | 0.00 |  |
| 163 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.102 | 6 | 0 | 70 | 0 | 3 | 69 | 0.04 | 0.00 | |
| 162 | Cellular Therapy and Transplantation | journal | 0.102 Q4 | 8 | 26 | 12 | 930 | 0 | 12 | 0.00 | 35.77 |  |
| 161 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.102 Q4 | 29 | 10 | 14 | 618 | 2 | 3 | 0.13 | 61.80 | |
| 160 | Chinese Journal of Cancer Biotherapy | journal | 0.103 Q4 | 5 | 133 | 260 | 3149 | 8 | 256 | 0.03 | 23.68 |  |
| 159 | Advances in Pharmacological Sciences | journal | 0.105 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 158 | Methods in Pharmacology and Toxicology | book series | 0.110 Q4 | 14 | 0 | 22 | 0 | 4 | 21 | 0.18 | 0.00 | |
| 157 | Probiotics and Antimicrobial Proteins | journal | 0.111 Q4 | 52 | 33 | 3 | 1287 | 0 | 3 | 0.00 | 39.00 | |
| 156 | Gene Therapy and Regulation | journal | 0.116 Q4 | 7 | 6 | 12 | 273 | 2 | 11 | 0.17 | 45.50 |  |
| 155 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.117 Q4 | 16 | 54 | 108 | 1944 | 17 | 108 | 0.16 | 36.00 | |
| 154 | Frontiers in Medicinal Chemistry | book series | 0.119 Q4 | 7 | 15 | 29 | 2233 | 3 | 28 | 0.10 | 148.87 |  |
| 153 | European Pharmaceutical Review | trade journal | 0.120 Q4 | 9 | 43 | 29 | 799 | 4 | 23 | 0.14 | 18.58 | |
| 152 | Open Medicinal Chemistry Journal | journal | 0.121 Q4 | 23 | 6 | 1 | 539 | 0 | 1 | 0.00 | 89.83 |  |
| 151 | Pharmacogenomics and Personalized Medicine | journal | 0.126 Q4 | 37 | 11 | 9 | 1260 | 3 | 9 | 0.33 | 114.55 |  |
| 150 | Open Pharmacology Journal | journal | 0.131 Q4 | 6 | 4 | 5 | 400 | 2 | 5 | 0.40 | 100.00 | |
| 149 | Current Cancer Therapy Reviews | journal | 0.146 Q4 | 17 | 34 | 101 | 3417 | 27 | 98 | 0.27 | 100.50 | |
| 148 | Journal of Stem Cells | journal | 0.157 Q4 | 21 | 5 | 59 | 195 | 18 | 58 | 0.31 | 39.00 | |
| 147 | Open Bioactive Compounds Journal | journal | 0.163 Q4 | 6 | 3 | 3 | 134 | 3 | 3 | 1.00 | 44.67 | |
| 146 | EXCLI Journal | journal | 0.167 Q4 | 55 | 20 | 28 | 630 | 17 | 27 | 0.61 | 31.50 | |
| 145 | Gene Therapy and Molecular Biology | journal | 0.174 Q4 | 18 | 0 | 100 | 0 | 51 | 100 | 0.57 | 0.00 |  |
| 144 | Virologica Sinica | journal | 0.177 Q4 | 47 | 52 | 184 | 1678 | 60 | 182 | 0.35 | 32.27 | |
| 143 | Expert Opinion on Medical Diagnostics | journal | 0.178 Q4 | 28 | 44 | 216 | 3835 | 117 | 215 | 0.64 | 87.16 | |
| 142 | Turkish Journal of Pharmaceutical Sciences | journal | 0.185 Q4 | 22 | 27 | 56 | 699 | 27 | 56 | 0.54 | 25.89 |  |
| 141 | Drug Discovery Today: Technologies | journal | 0.193 Q4 | 62 | 35 | 50 | 1374 | 35 | 43 | 0.69 | 39.26 | |
| 140 | Molecular Medicine Reports | journal | 0.193 Q4 | 86 | 166 | 299 | 4924 | 99 | 299 | 0.33 | 29.66 | |
| 139 | Biomolecules and Therapeutics | journal | 0.212 Q4 | 56 | 60 | 126 | 2263 | 66 | 126 | 0.52 | 37.72 |  |
| 138 | Personalized Medicine | journal | 0.215 Q4 | 36 | 92 | 200 | 2879 | 136 | 161 | 0.69 | 31.29 | |
| 137 | Journal of Biological Sciences (discontinued) | journal | 0.218 Q4 | 38 | 107 | 633 | 4093 | 289 | 633 | 0.49 | 38.25 |  |
| 136 | Journal of Cardiovascular Translational Research | journal | 0.218 Q4 | 60 | 84 | 130 | 5176 | 68 | 118 | 0.52 | 61.62 | |
| 135 | Current Chemical Genomics | journal | 0.226 Q4 | 16 | 8 | 8 | 255 | 5 | 8 | 0.63 | 31.88 | |
| 134 | Yaoxue Xuebao | journal | 0.236 Q4 | 36 | 259 | 704 | 5323 | 422 | 703 | 0.64 | 20.55 | |
| 133 | Pteridines | journal | 0.238 Q4 | 19 | 10 | 39 | 329 | 23 | 38 | 0.44 | 32.90 | |
| 132 | Pharmaceuticals | journal | 0.243 Q4 | 87 | 185 | 23 | 18278 | 15 | 22 | 0.65 | 98.80 |  |
| 131 | Current Enzyme Inhibition | journal | 0.245 Q4 | 19 | 23 | 65 | 2088 | 47 | 65 | 0.60 | 90.78 | |
| 130 | Frontiers in Drug Design and Discovery | book series | 0.246 Q4 | 9 | 0 | 41 | 0 | 33 | 39 | 0.56 | 0.00 | |
| 129 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.252 Q4 | 39 | 32 | 92 | 2790 | 87 | 90 | 0.95 | 87.19 | |
| 128 | Letters in Drug Design and Discovery | journal | 0.256 Q4 | 37 | 114 | 283 | 3563 | 217 | 283 | 0.70 | 31.25 | |
| 127 | Current Pharmacogenomics and Personalized Medicine | journal | 0.281 Q3 | 20 | 32 | 53 | 2735 | 60 | 48 | 1.13 | 85.47 | |
| 126 | Biomarker Insights | journal | 0.286 Q3 | 40 | 19 | 63 | 621 | 61 | 62 | 0.97 | 32.68 | |
| 125 | Topics in Medicinal Chemistry | book series | 0.306 Q3 | 15 | 15 | 10 | 1612 | 7 | 8 | 0.70 | 107.47 | |
| 124 | Pharmaceutical Biology | journal | 0.315 Q3 | 88 | 227 | 440 | 6719 | 374 | 434 | 0.78 | 29.60 | |
| 123 | Drug Discovery Today: Disease Mechanisms | journal | 0.317 Q3 | 28 | 31 | 89 | 1578 | 79 | 78 | 0.87 | 50.90 | |
| 122 | Drug Discovery Today: Therapeutic Strategies | journal | 0.319 Q3 | 31 | 12 | 101 | 524 | 71 | 86 | 0.71 | 43.67 | |
| 121 | Drug Discovery Today: Disease Models | journal | 0.330 Q3 | 33 | 19 | 96 | 746 | 62 | 82 | 0.65 | 39.26 | |
| 120 | Journal of Asian Natural Products Research | journal | 0.350 Q3 | 51 | 159 | 488 | 2639 | 419 | 488 | 0.79 | 16.60 | |
| 119 | Future Cardiology | journal | 0.373 Q3 | 43 | 76 | 185 | 5052 | 145 | 151 | 1.08 | 66.47 | |
| 118 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.422 Q3 | 53 | 99 | 490 | 2123 | 455 | 489 | 1.17 | 21.44 | |
| 117 | SAR and QSAR in Environmental Research | journal | 0.435 Q3 | 54 | 44 | 132 | 2032 | 311 | 129 | 2.18 | 46.18 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data